Free Account Opening + AMC Free Demat
Loading...

Mankind Pharma IPO vs Udayshivakumar Infra IPO

Comparision between Mankind Pharma IPO and Udayshivakumar Infra IPO.

IPO Details

Mankind Pharma IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Udayshivakumar Infra IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Mankind Pharma IPO is up to ₹4,326.36 Cr whereas the issue size of the Udayshivakumar Infra IPO is up to ₹66.00 Cr. The final issue price of Mankind Pharma IPO is ₹1,080.00 per share and of Udayshivakumar Infra IPO is ₹35.00 per share.

  Mankind Pharma IPO Udayshivakumar Infra IPO
Face Value ₹1 per share ₹10 per share
Issue Price (Lower) ₹1,026.00 per share ₹33.00 per share
Issue Price (Upper) ₹1,080.00 per share ₹35.00 per share
Issue Price (Final) ₹1,080.00 per share ₹35.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 13 shares 428 shares
Fresh Issue Size 2,00,00,000 shares
Fresh Issue Size (Amount) up to ₹66.00 Cr
OFS Issue Size 4,00,58,844 shares
OFS Issue Size (Amount) up to ₹4,326.36 Cr
Issue Size Total 4,00,58,844 shares 2,00,00,000 shares
Issue Size Total (Amount) up to ₹4,326.36 Cr up to ₹66.00 Cr

IPO Timetable

Mankind Pharma IPO opens on Apr 25, 2023, while Udayshivakumar Infra IPO opens on Mar 20, 2023. The closing date of Mankind Pharma IPO and Udayshivakumar Infra IPO is Apr 27, 2023, and Mar 23, 2023, respectively.

  Mankind Pharma IPO Udayshivakumar Infra IPO
Anchor Bid Date Apr 24, 2023 Mar 17, 2023
Issue Open Apr 25, 2023 Mar 20, 2023
Issue Close Apr 27, 2023 Mar 23, 2023
Basis Of Allotment (Tentative) May 03, 2023 Mar 28, 2023
Initiation of Refunds (Tentative) May 04, 2023 Mar 29, 2023
Credit of Share (Tentative) May 05, 2023 Mar 31, 2023
Listing date (Tentative) May 09, 2023 Apr 03, 2023
Anchor Lockin End date 1 Jun 02, 2023 Apr 27, 2023
Anchor Lockin End date 2 Aug 01, 2023 Jun 26, 2023

Financials

Mankind Pharma IPO P/E ratio is 32.5, as compared to Udayshivakumar Infra IPO P/E ratio of 9.67.

  Mankind Pharma IPO Udayshivakumar Infra IPO
Financial
Mankind Pharma Limited Financial Information (Restated Consolidated)
Period EndedTotal AssetsTotal RevenueProfit After TaxNet WorthReserves and SurplusTotal Borrowing
31-Mar-205,073.295,975.651,056.153,485.313,436.34126.92
31-Mar-216,372.636,385.381,293.034,722.004,674.39234.53
31-Dec-218,043.886,218.291,260.245,965.465,916.86268.70
31-Mar-229,147.747,977.581,452.966,155.236,106.06868.03
31-Dec-229,273.756,777.821,015.987,145.897,094.12167.93
Amount in ₹ Crore
Udayshivakumar Infra Limited Financial Information (Restated)
Period EndedTotal AssetsTotal RevenueProfit After TaxNet WorthTotal Borrowing
31-Mar-20158.26194.4110.4946.8733.95
31-Mar-21146.82211.119.3256.1830.60
31-Mar-22162.61186.3912.1568.3226.48
30-Sep-22178.90107.1410.0278.3439.46
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue) 79.00% 100.00%
Promoter Shareholding (Post-Issue) 76.50% 65.9%
P/E Ratio 32.5 9.67
Market Cap ₹43263.60 Cr. ₹193.75 Cr.
ROE 27.60%% 17.80%%
ROCE 26.10%% 20.71%%
Debt/Equity 0.16
EPS ₹33.20
RoNW 27.70%%

Shares Offered

In the Mankind Pharma IPO retail investors (RII) are offered 1,40,20,596 shares while in Udayshivakumar Infra IPO retail investors are offered 1,40,20,596 shares. Qualified institutional buyers (QIB) are offered 80,11,769 shares in Mankind Pharma IPO and 18,85,715 shares in Udayshivakumar Infra IPO.

  Mankind Pharma IPO Udayshivakumar Infra IPO
Anchor Investor Reserveration 1,20,17,652 shares
Market Maker Reserveration
QIB 80,11,769 shares 18,85,715 shares
NII 60,08,827 shares 56,57,142 shares
RII 1,40,20,596 shares 1,13,14,285 shares
Employee 0 shares 0 shares
Others
Total 2,80,41,192 shares 1,88,57,142 shares

Bids Received (Subscription)

Mankind Pharma IPO subscribed 15.32x in total, whereas Udayshivakumar Infra IPO subscribed 32.49x.

  Mankind Pharma IPO Udayshivakumar Infra IPO
QIB (times) 49.16x 42.92x
NII (times) 3.80x 64.08x
Big NII (times) 4.99x 63.54x
Small NII (times) 1.41x 65.14x
RII (times) 0.92x 14.95x
Employee (times)
Other (times)
Total (times) 15.32x 32.49x

Comments

Add a public comment...